QC

Lonza is one of the world’s leading and most-trusted suppliers to the pharmaceutical, biotech and specialty ingredients markets. We harness science and technology to create products that support safer and healthier living and that enhance the overall quality of life.

Post : Chemist Quality Control

Established during the ‘Swadeshi Movement’ of India, Biological E. Limited (BE) started during a time when the nation sought access to critical healthcare products. Founded and led by Dr. DVK Raju, Biological E. Limited commenced its operations in 1953 as a biological products company manufacturing liver extracts and anti-coagulants. With an objective of transitioning from treating diseases to preventing them, Biological E. Limited launched its Biotechnology Division (now Vaccines and Biologics Division) and commenced large-scale production of DPT vaccines as early as 1962.

Hetero Healthcare is a Pharmaceutical Manufacturing Company with its head quartered at Hyderabad. We catered to different product of various therapeutic groups. We aim to improve the quality life of the people with our product line and along with a continuous Research and Development process. Hetero Health Care team uses all its experience which it has gained from over a century to add its benefits for the development of human life span.

Unison Pharmaceuticals Private Limited (Formerly known as Unison Pharmaceuticals) was established in 1981 with a vision of providing quality & most affordable medicines across the nation. With more than 3 decades of medical service to the society, Unison is today one of the fastest growing company in Gujarat State. The base of operation being a single state, the company has very strong footing in the market. The company strictly believes in ethics and moral values throughout the operations of the business.

HSN is a healthcare company in Haridwar, Uttarakhand (India), established and formed in the year 2007. HSN has established an ultra modern facility as per cGMP standards to manufacture tablets, oral liquid and ointment. HSN International has come up with new unit, HSN Biotech- it is a manufacturing entity having huge capacity to manufacture million of tablets and oral liquids per day. The firm is committed to promoting healthcare.

Dano Vaccines and Biologicals Private Limited is one of the experienced manufacturer of Tetanus Toxoid (T.T) Vaccine since 1985. Dano is involved in manufacturing and distribution of Tetanus Toxoid (T.T) Vaccine for the past 36 years. Our mission is to provide quality and affordable life-saving vaccines.

Biogen pharmaceutical co’s services continue to care from prevention and cure. Biogen pharmaceutical co is devoted to the Innovation, manufacture, co-market and export of Pharmaceuticals and hospital products for Human. Biogen pharmaceutical co will ensures its presence in Indian markets for its products and services to companies with marketing alliance. Biogen pharmaceutical co today, has a strong reputation in marketing to the healthcare solutions.

Aalidhra Pharmachem is an (ISO 9001, 14001, OHSAS 18001 and Schedule M certified) Pharmaceutical Intermediates AND API manufacturing company established in 2015. We are working very closely with our customers to develop API opportunities to provide alternative, more economical, second-source options for existing generic drugs. By leveraging our worldwide sourcing, regulatory and quality assurance capabilities, we provide to generic drug manufacturers an alternative, economical source for existing API products. We, at Aalidhra Pharmachem Pvt. Ltd.

The 11th Annual Clinical Trials Summit 2020 to be held in Mumbai, India during 28th May 2020. The global Contract Research Organization (CRO) market size was estimated at US$ 34.5 billion in 2018 and is projected to reach US$ 55.3 billion by 2024, growing at a CAGR of 8.2% during 2019 to 2024. Indian clinical trials market size is expected to reach US$ 3.15 billion by 2025. It is projected to register a CAGR of 8.7% over the forecast period.Increasing cost of drug development is expected to drive the growth. Drug maker and sponsor companies are under pressure to replace the revenue loss caused by generics, increasing patent expiry, number of partnerships to identify biologics, and growing R&D costs, which has made drug development more expensive and complex. In addition, growing pressure on market players to follow stringent timelines has increased the demand for outsourcing of research activities.This Conference brings together Researchers, Doctors, Principle Investigators, Clinical research sites, CROs, CMOs, Investors, and senior executives from Biopharma, Medical devices and Pharmaceutical industries around the globe to discuss, reflect on and develop their ideas.